Citra Buana Prasida Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Citra Buana Prasida Tbk. trades at Rp535 (market cap 725.59B, 295.9K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 17.3× Citra Buana Prasida Tbk.'s market cap, and Citra Buana Prasida Tbk. is more actively traded (295.9K versus 235.2K). Which is the better fit depends on your goals.
| CBPE | TSPC | |
|---|---|---|
Market Cap | 725.59B | 12.58T |
Volume | 295.9K | 235.2K |
Lot | 2.96K | 2.35K |
Turnover | 165.79M | 649.94M |
Average Price | 560.28 | 2,763.37 |
Value | 165.79M | 649.94M |
Indicative Equilibrium Price | 580 | 2,780 |
Indicative Equilibrium Volume | 526 | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Buana Prasida Tbk Entity which was originally named PT Prasetia Sejati was established on August 24, 2000 based on the Deed of Establishment No. 18, drawn up in the presence of Ninik Sukadarwati, SH., Notary of the Bekasi Regency Level II, in Tambun. The Entity started its commercial business in 2005.
Read more on CBPE →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →